SmartMoneyDB

MLTXMOONLAKE IMMUNOTHERAPEUTICS

CLASS A ORD · CUSIP 61559X104

MLTX (MOONLAKE IMMUNOTHERAPEUTICS) Institutional Ownership Summary

Based on the latest SEC 13F filings, 4 institutional investors hold MLTX (MOONLAKE IMMUNOTHERAPEUTICS) with a combined value of $45.98M across 3,488,855 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $30.25M (0.00% of their portfolio). 4 funds increased their holdings.

Total Institutional Value

$45.98M

Total Shares Held

3,488,855

Institutional Holders

4

13F Institutional Holders

#FundValuePortfolio %Change
1CITADEL ADVISORS LLC$30.25M0.00%+318.7%
2Point72 Asset Management, L.P.$10.18M0.01%+7782.7%
3BlackRock, Inc.$3.78M0.00%+128.6%
4RENAISSANCE TECHNOLOGIES LLC$1.77M0.00%+0.0%